CCK
Selected indexed studies
- Cholecystokinin (CCK): a neuromodulator with therapeutic potential in Alzheimer's and Parkinson's disease. (Front Neuroendocrinol, 2024) [PMID:38346453]
- (99m)Tc(N)(NS-Cys-Gly-CCK-8)(PNP3). (, 2004) [PMID:20641448]
- Effects of CCK on pancreatic function and morphology. (Ann N Y Acad Sci, 1994) [PMID:8185159]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Cholecystokinin (CCK): a neuromodulator with therapeutic potential in Alzheimer's and Parkinson's disease. (2024) pubmed
- [(99m)Tc(N)(NS-Cys-Gly-CCK-8)(PNP3)](+). (2004) pubmed
- Effects of CCK on pancreatic function and morphology. (1994) pubmed
- CCK in anxiety and cognitive processes. (1998) pubmed
- Involvement of endogenous CCK and CCK1 receptors in colonic motor function. (2004) pubmed
- CCK antagonists and CCK-monoamine interactions in the control of satiety. (1992) pubmed
- The role of CCK caerulein, and CCK antagonists in nociception. (1989) pubmed
- Natural and synthetic CCK-58. Novel reagents for studying cholecystokinin physiology. (1994) pubmed
- Major biological actions of CCK--a critical evaluation of research findings. (1998) pubmed
- What we know and what we need to know about the role of endogenous CCK in psychostimulant sensitization. (2003) pubmed